TUESDAY, SEPTEMBER 27, 2016

HHS seeks contractors to test malaria vaccines

The U.S. Department of Health and Human Services, through the National Institutes of Health's Allergy and Infectious Diseases unit, is seeking contractor proposals for testing new malaria vaccines, the NIH said recently.

The mission of the Laboratory of Malaria Immunology and Vaccinology (LMIV) is to develop malaria vaccines, and the lab requires the assistance of contractors that can conduct clinical trials to investigate initial safety, efficacy, immunogenicity and the biological impact of promising LMIV-developed vaccines.

In certain situations, the LMIV also may require that select contractors conduct clinical studies of pathogenesis research to facilitate and supervise the vaccine’s development.

The proposed award date for funding proposed studies is Oct. 1. The deadline to submit proposals is March 12.

Per the NIH, the classification code for the studies is “A -- Research & Development,” and the NAICS Code is “541 -- Professional, Scientific and Technical Services/541711 -- Research and Development in Biotechnology.”

The studies will be performed at the NIH's National Institute of Allergy and Infectious Diseases unit in Rockville, Maryland.

For more information, interested parties should contact Contract Specialist Alice Sobsey at 240-669-5118 (alice.sobsey@nih.gov) or Contracting Officer Dixie Harper at 240-669-5119 (dixie.harper@nih.gov).

Organizations in this story

U.S. Department of Health and Human Services (HHS) 200 Independence Avenue Southwest Washington, DC 20201

Get notified the next time we write about U.S. Department of Health and Human Services (HHS)!